Browse > Article
http://dx.doi.org/10.5483/BMBRep.2020.53.11.055

Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein  

Hwang, Supyong (Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center)
Kim, Soyoung (Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center)
Kim, Kyungkon (Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center)
Yeom, Jeonghun (Convergence Medicine Research Center (CREDIT), ASAN Institute for Life Sciences, ASAN Medical Center)
Park, Sojung (Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center)
Kim, Inki (Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center)
Publication Information
BMB Reports / v.53, no.11, 2020 , pp. 576-581 More about this Journal
Abstract
Dimethylation of the histone H3 protein at lysine residue 9 (H3K9) is mediated by euchromatin histone methyltransferase II (EHMT2) and results in transcriptional repression of target genes. Recently, chemical inhibition of EHMT2 was shown to induce various physiological outcomes, including endoplasmic reticulum stress-associated genes transcription in cancer cells. To identify genes that are transcriptionally repressed by EHMT2 during apoptosis, and cell stress responses, we screened genes that are upregulated by BIX-01294, a chemical inhibitor of EHMT2. RNA sequencing analyses revealed 77 genes that were upregulated by BIX-01294 in all four hepatic cell carcinoma (HCC) cell lines. These included genes that have been implicated in apoptosis, the unfolded protein response (UPR), and others. Among these genes, the one encoding the stress-response protein Ras-related GTPase C (RRAGC) was upregulated in all BIX-01294-treated HCC cell lines. We confirmed the regulatory roles of EHMT2 in RRAGC expression in HCC cell lines using proteomic analyses, chromatin immune precipitation (ChIP) assay, and small guide RNA-mediated loss-of-function experiments. Upregulation of RRAGC was limited by the reactive oxygen species (ROS) scavenger N-acetyl cysteine (NAC), suggesting that ROS are involved in EHMT2-mediated transcriptional regulation of stress-response genes in HCC cells. Finally, combined treatment of cells with BIX-01294 and 5-Aza-cytidine induced greater upregulation of RRAGC protein expression. These findings suggest that EHMT2 suppresses expression of the RRAGC gene in a ROS-dependent manner and imply that EHMT2 is a key regulator of stress-responsive gene expression in liver cancer cells.
Keywords
BIX-01294; EHMT2; Epigenetics; ER stress; RRAGC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Stewart MD, Li J and Wong J (2005) Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol 25, 2525-2538   DOI
2 Kim Y, Kim YS, Kim DE et al (2013) BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 9, 2126-2139   DOI
3 Huang Y, Zou Y, Lin L, Ma X and Huang X (2017) Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells. Leuk Res 62, 34-39   DOI
4 Sancak Y, Peterson TR, Shaul YD et al (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501   DOI
5 Kim E, Goraksha-Hicks P, Li L, Neufeld TP and Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10, 935-945   DOI
6 Jewell JL, Russell RC and Guan KL (2013) Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14, 133-139   DOI
7 Guha P, Kaptan E, Gade P, Kalvakolanu DV and Ahmed H (2017) Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1. Oncotarget 8, 68191-68207   DOI
8 Namgung Y, Kim SY and Kim I (2019) Down-regulation of survivin by BIX-01294 pretreatment overcomes resistance of hepatocellular carcinoma cells to TRAIL. Anticancer Res 39, 3571-3578   DOI
9 Hyun K, Jeon J, Park K and Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49, e324   DOI
10 Chen Z, Li S, Subramaniam S, Shyy JY and Chien S (2017) Epigenetic Regulation: A new frontier for biomedical engineers. Annu Rev Biomed Eng 19, 195-219   DOI
11 Herz HM, Garruss A and Shilatifard A (2013) SET for life: biochemical activities and biological functions of SET domaincontaining proteins. Trends Biochem Sci 38, 621-639   DOI
12 Yokoyama M, Chiba T, Zen Y et al (2017) Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Oncotarget 8, 21315-21326   DOI
13 Fritsch L, Robin P, Mathieu JR et al (2010) A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 37, 46-56   DOI
14 Casciello F, Windloch K, Gannon F and Lee JS (2015) Functional role of G9a histone methyltransferase in cancer. Front Immunol 6, 487   DOI
15 Kondo Y, Shen L, Suzuki S et al (2007) Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res 37, 974-983   DOI
16 Wei L, Chiu DK, Tsang FH et al (2017) Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol 67, 758-769   DOI
17 Kim SY, Hong M, Heo SH et al (2018) Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen speciesmediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. Mol Carcinog 57, 1492-1506   DOI
18 Esteve PO, Chin HG, Smallwood A et al (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20, 3089-3103   DOI
19 Jones PA and Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428   DOI
20 Park SE, Yi HJ, Suh N et al (2016) Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-kappaB. Oncotarget 7, 39796-39808   DOI